Where Sunscreen Sits Between MoCRA and OTC Drug Rules

A moisturizer with SPF 30 sits in an odd spot, and I get asked about it constantly. Is it a cosmetic that needs MoCRA listing, or a drug that needs something else entirely? The honest answer is that it's mostly the drug side, and understanding why clears up a lot of confusion for anyone making a dual-function product.

The core distinction

In the US, sunscreen is regulated as an over-the-counter (OTC) drug, not a cosmetic. That's a fundamentally different regulatory lane than MoCRA, which governs cosmetics. Drug status comes from the claim: a product that claims to protect against or prevent something, in this case UV damage or sunburn, is making a drug claim, not a cosmetic one. Cosmetic claims are about appearance and cleansing, drug claims are about affecting the body's structure or function or preventing disease.

This is the same logic that applies to anti-acne, anti-dandruff, antiperspirant, and fluoride toothpaste products. All of them are typically drugs, not cosmetics, because of what they claim to do, regardless of how similar their physical form is to an ordinary cosmetic.

What that means practically

If your product is sunscreen alone, or sunscreen plus incidental cosmetic benefits, the primary regulatory pathway is the OTC drug framework, not MoCRA's facility registration and product listing requirements. That's a genuinely different set of obligations, generally involving different testing, labeling, and manufacturing standards than a straightforward cosmetic.

Where it gets genuinely tricky is the dual-function product. A tinted moisturizer with SPF, a lip balm with SPF, a daily face cream marketed on both hydration and sun protection, all of these carry both a cosmetic identity and a drug identity at once. In US practice, these are usually treated by dividing the product's obligations: the drug component (the SPF claim and its active ingredient) follows OTC drug rules, while other aspects of the product can still carry cosmetic-style marketing and ingredient considerations.

Why this distinction actually matters for your business

Getting this wrong isn't a paperwork inconvenience, it's a different set of legal obligations entirely:

• OTC drug products have their own active ingredient approval framework, separate from cosmetic ingredient safety substantiation
• Manufacturing standards for OTC drugs are generally more rigorous than cosmetic GMP guidance
• Labeling requirements for drug facts differ substantially from cosmetic ingredient list conventions
• MoCRA's adverse event recordkeeping and responsible person requirements were built around cosmetics and don't substitute for drug-side obligations

If you're a small soap or skincare maker who has been filing cosmetics comfortably and you're now eyeing an SPF line extension because customers keep asking for it, don't assume you can bolt an SPF claim onto your existing cosmetic process. That's a materially different regulatory undertaking, generally requiring separate expertise from your existing cosmetic compliance workflow.

A simple self-check

Question	If yes
Does the label claim to prevent or protect against a condition (sunburn, UV damage)?	Likely drug territory
Does the label only claim to moisturize, cleanse, or improve appearance?	Likely cosmetic territory
Does the product do both, with an active sun-protection ingredient?	Dual identity, drug rules apply to the SPF portion

This isn't a substitute for a real regulatory read of your specific label copy and formula, but it's a fast way to flag whether you're potentially in OTC drug territory before you get further down a cosmetic filing path that won't actually cover you.

The MoCRA side still exists for non-SPF products

None of this diminishes MoCRA's relevance to the rest of your catalog. Your facility registration, product listing, responsible person designation, and safety substantiation obligations under MoCRA apply fully to your genuinely cosmetic products, lotions without SPF claims, cleansers, fragrance products, and so on. It's specifically the sunscreen-claiming products that step outside that lane.

Cosmetic Comply's current focus is squarely on cosmetic filings, starting with Canada and expanding toward the US, EU, and Australia, and that scope is intentional. If a chunk of your catalog is genuinely cosmetic and a smaller SPF line sits in OTC drug territory, it's worth keeping those two workflows mentally and administratively separate from day one, rather than discovering the distinction after a label review flags it for you.